AI 导读
Anthropic 收购一人生物技术公司 Mithril Medicine，开始开展自己的药物研发，此前还与六个新药研发组织进行了深度研究合作。其创始人 Cody Tranbarger 用 Claude 组织与 11 个外部实验室的合同、物流和实验，把一种罕见肌肉萎缩症的潜在疗法在不到 18 个月内从想法推进到小鼠中的积极结果；若候选药物继续有效，预计最早 2028 年底开始人体临床试验。
推荐理由
原文给出收购对象、18 个月小鼠结果和临床时间线等细节，可用于评估 Claude 在药物研发中的实际作用。
正文
Anthropic is now doing its own drug discovery after acquiring one-person biotech startup Mithril Medicine!
With Claude and 11 external labs, its founder took a potential treatment for a rare form of muscular dystrophy from idea to promising results in mice in under 18 months.
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences. https://www.anthropic.com/research/early-progress-drug-development在 X 查看被引用的帖子
来源：Chubby♨️ · x.com